White label – Pompe disease - ClinicalTrials.eu

Study of tazemetostat combined with lenalidomide and rituximab in adult patients with relapsed or refractory follicular lymphoma

Recruiting

3 1 1
Investigated Diseases:
- Follicular lymphoma
Investigated Drugs:
+1
Study on the Use of Gallium Citrate Ga-68 for Diagnosing Chronic Infections in Artificial Hip and Knee Joints

Recruiting

2 1 1
Investigated Diseases:
- Medical device site joint infection
Investigated Drugs:
- Gallium Citrate Ga-68
Study of ADS-010 for Adults with Facioscapulohumeral Muscular Dystrophy Type 1

Recruiting

2 1 1
Investigated Diseases:
- Facioscapulohumeral muscular dystrophy
Investigated Drugs:
- Ads-010
- Sodium Chloride
Study on the Effect of Levobupivacaine in Reducing Chronic Pain After Open Inguinal Hernia Repair in Patients

Recruiting

3 1 1 1
Investigated Diseases:
Study on Leflunomide for Preventing Relapses in Patients with Polymyalgia Rheumatica During Steroid Reduction

Recruiting

3 1 1 1
Investigated Diseases:
- Polymyalgia rheumatica
Investigated Drugs:
- Leflunomide
- Placebo
Study of Nivolumab and Nivolumab Plus Relatlimab for Patients with Advanced or Metastatic Skin Squamous Cell Carcinoma

Recruiting

2 1 1 1
Investigated Diseases:
- Squamous cell carcinoma of skin
Investigated Drugs:
- Nivolumab
- Relatlimab
Study on Zanidatamab with Cisplatin and Gemcitabine for Advanced HER2 Positive Biliary Tract Cancer Patients

Recruiting

3 1 1 1
Investigated Drugs:
+4
Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis

Recruiting

3 1 1
Investigated Drugs:
- Anifrolumab
+7
Study on Surgical Treatment with or without Apalutamide for Patients with High-Risk Prostate Cancer Eligible for Radical Prostatectomy

Recruiting

2 1 1 1
Investigated Diseases:
- Prostate cancer metastatic
Investigated Drugs:
- Apalutamide
Study on the Effects of Clodronate Disodium for Patients with Painful Knee Osteoarthritis

Recruiting

4 1
Investigated Diseases:
- Osteoarthritis
Investigated Drugs:
- Clodronate Disodium

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies